Community/Retail

Allison Hanson, PharmD, BCPS, the 2019-2020 Institute for Safe Medication Practices (ISMP) International Medication Safety Management Fellow, discusses medication safety during the COVID-19 pandemic.

Amid ongoing protests across the country, pharmacy staff and owners are seeking ways to stay safe and avoid damage or looting.

The study contributes to a growing body of research suggesting that fitness has beneficial effects for brain health, applying magnetic resonance spectroscopy to detect and measure brain metabolites, focusing specifically on N-acetyl aspartic acid (NAA).

Technicians and pharmacists both agreed that the Optimizing Care Model allowed the pharmacy to implement entirely new services and expand the number of patients who were receiving existing services.

Business planning includes many components, not just merely generating an idea and hoping it will succeed.

Telemedicine and connected devices are emerging as technologies to provide greater access and convenience to care for those who can defer treatment by way of an in-person consultation.

Sub-optimally managed pain is the outcome of a reactionary position to the opioid epidemic.

According to a new survey released by the NCPA, COVID-19 is changing how local pharmacies do business across the country, and these changes may be for the long term.

It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs during the coronavirus disease 2019 (COVID-19) pandemic.

Pharmacy Times® interviewed Benjamin McNabb, PharmD, the owner of Love Oak Pharmacy, about the path ahead in managing COVID-19 guidelines and supporting safe practices in pharmacies when reopening.

This marks the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in patients with a high cardiovascular risk but without a history of heart attack or stroke.

Consumers report a very high level of comfort with COVID-19 testing at community pharmacies and was similar to the level of comfort respondents reported among hospitals and urgent care facilities.

Today, we’re celebrating Edris Kosar, PharmD, founder and owner of Banadir Pharmacy in Minneapolis, Minnesota.

Nearly half of community pharmacies offer long-term care services and play a critical role in ensuring patients have immediate access to medications in long-term care settings.

Today, we’re celebrating Todd Raehtz, RPh, owner of Grass Lake Community Pharmacy in Grass Lake, Michigan.

The process of becoming certified in itself instills a greater sense of belonging in pharmacy among technicians.

Oriahnn is the first FDA-approved nonsurgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women

How did switching from name brand to generic cause a child’s death?

Pharmacy Times® spoke with Jennifer Craig, PharmD, CSP, about Skin Cancer Awareness Month and the importance of skin care.

A new law approved in Minnesota this week expands pharmacists’ authority by allowing them to administer FDA-authorized COVID-19 or SARS-CoV-2 vaccines when they become available.

Artificial intelligence will inevitably play a major role in hub services, improving efficiency and speed to therapy.

Pharmacy Times® interviewed James Krellenstein, co-Founder, PrEP4All Collaboration and Organizer, The COVID-19 Working Group, to discuss the development of PrEP for the COVID-19 pandemic.

FDA has granted Fast Track designation to Cardiff Oncology’s onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

Pharma companies that shift their attention to what providers, payers, and patients are asking for will profit from the growing worldwide market on preventative care.

Today, we’re celebrating the work of Dan McCoy, PharmD, a pharmacist at CVS in Madison, Wisconsin.

The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).

Despite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.

New York Governor Andrew Cuomo announced last week that New York will launch a COVID-19 testing pilot program with a goal of conducting 7000 tests per week.